The MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality

dc.contributor.authorSaab, Sammy
dc.contributor.authorLandaverde, Carmen
dc.contributor.authorIbrahim, Ayman B.
dc.contributor.authorDurazo, Francisco
dc.contributor.authorHan, Steven
dc.contributor.authorYersiz, Hasan
dc.contributor.authorFarmer, Douglas G
dc.contributor.authorGhobrial, R Mark
dc.contributor.authorGoldstein, Leonard I.
dc.contributor.authorTong, Myron J.
dc.contributor.authorBusuttil, Ronald W.
dc.date.accessioned2025-10-06T16:43:20Z
dc.date.issued2006-06
dc.description.abstractBackground: The Model for End-Stage Liver Disease (MELD) score is a measure of chronic liver disease severity. Patients awaiting transplantation are assessed using this score. However, it has recently been suggested that changes in MELD score may be as important as the absolute MELD score in predicting short-term survival. However, clinical factors that affect the MELD score are unknown. We sought to identify predictors of mortality for potential transplant patients and examine factors that might predict changes in MELD score. Materials and Methods: Between January 1, 2002, and July 30, 2004, we retrospectively examined risk factors of 429 adult patients awaiting liver transplantation at the University of California at Los Angeles (UCLA). Analysis of the data was performed using demographics, manifestations of portal hypertension, time between last MELD recorded and event, and laboratory values. Significant factors in univariate analysis were further studied using Cox proportional hazards regression multivariate analysis. Results: At mean follow-up of 2.15 years (± 1.49 years), 71 patients (16.5%) had MELD scores that increased 5-10 points, 22 had changes of 10-15 points, and 14 had changes of 15-20 points. Manifestations of portal hypertension, laboratory values, and etiology of liver disease did not predict changes in MELD score. However, development of hepatic encephalopathy (HR, 3.95; P = .002; 95% CI, 1.70 to 9.42) and MELD score (HR, 1.04; P = .001; 95% CI, 1.004 to 1.08) were associated with variceal bleeding. Also, MELD score (HR, 1.07; P < .001; 95% CI, 1.05 to 1.09), refractory ascites (HR, 2.15; P = .002; 95% CI, 1.31 to 3.53), and alcoholic cirrhosis (HR, 0.40; P = .04; 95% CI, 0.18 to 0.94) were independent predictors of mortality. Conclusions: Encephalopathy and MELD score were associated with variceal bleeding. Patients with an elevated MELD score, refractory ascites, and alcoholic cirrhosis had increased mortality while on the liver transplant list. No factors predicting changes in the MELD score were identified.
dc.identifier.citationExperimental and Clinical Transplantation, Cilt 4, Sayı 1, 2006, ss. 395-399en
dc.identifier.eissn2146-8427en
dc.identifier.issn1304-0855
dc.identifier.issue1en
dc.identifier.urihttps://hdl.handle.net/11727/13677
dc.identifier.volume4en
dc.language.isoen_US
dc.publisherBaşkent Üniversitesi
dc.sourceExperimental and Clinical Transplantationen
dc.subjectMELD
dc.subjectLiver transplantation
dc.subjectOutcome
dc.titleThe MELD Score in Advanced Liver Disease: Association with Clinical Portal Hypertension and Mortality
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
pdfPreview.php.pdf
Size:
120.76 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: